Mission

Over the past decade, progress on controlling communicable diseases such as HIV/AIDS, malaria, and tuberculosis in low and middle-income countries (LMICs) around the globe has coincided with the rise of cancer in these communities. According to a landmark study, LMICs carry more than 80% of the global cancer burden but have access to only 5% of the resources needed to control cancer.


State-of-the-art cancer care is not available in many of the world’s LMICs because of high investment costs and high resource-demand. For example, cancer centers often use outdated equipment and very simplified techniques. These treatments are approximately 40 years behind what can be accomplished for cancer patients in higher income countries.

Unfortunately, there are limited educational paths available to develop expertise in cancer care in LMICs. To empower clinicians to independently provide effective oncology services in their communities, GACCF supports comprehensive clinical training programs to create a core base of local experts.

Donate Now

Help Us Teach Hope Around the World. Donate Now.

GACCF Management

The GACCF Board of Directors

The GACCF Advisory Board

  • Markus Lang

    Commercial Banking Relationship Manager at U.S. Bank

  • Harvey Grant

    Former NBA Player

  • Vicki Paladino

    Director of Sales and Philanthropy

  • Björn Albrecht

    Partner & Head of McKinsey Cancer Center, McKinsey & Company

  • Sarah Chapman

    Global Chief Sustainability Officer at Manulife

  • Dr. Pankaj Chaturvedi

    Head Neck Cancer Surgeon and Deputy Director, Tata Memorial Centre, Mumbai.

  • John Einck

    Professor of Radiation Medicine, University of California San Diego; President, Radiating Hope

  • Patricia Harrigan Hardenbergh, MD

    Medical Director, Shaw Regional Cancer Center; Founder, Chartrounds, LLC

  • Shruti Jolly, MD

    Professor of Radiation Oncology and Associate Medical Director of Strategy, University of Michigan

  • Brady Forseth

    CEO, African Community & Conservation Foundation (ACCF)

  • Prof. Luca Incrocci, MD PhD

    Professor of Genito-Urinary Radiotherapy, Erasmus Medical Center Cancer Institute

  • Dr. Wilfred Ngwa

    Associate Professor (PAR) of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins

  • Steven Ogunro

    Partner, Capital Mergers And Acquisitions, LLC

  • Dr. Jeannette Parkes

    Professor and Head of Division Radiation Oncology, Groote Schuur Hospital and University of Cape Town

  • Wilko Verbakel

    Senior Medical Physicist and Associate Professor, Amsterdam UMC, Netherlands

  • Dr. Vijay Anand Reddy

    Director and Professor, Department of Oncology, Apollo Cancer Institute, Apollo Hospital

  • Stephen D. Robb, MD

    Worldwide Solid Tumors Franchise Medical Head at Novartis

  • Michael Sandhu

    CEO, remediumRT AG

  • Mira Shah

    Resident in Radiation Oncology, Henry Ford Hospital; Vice President, Radiating Hope

  • Jon S. Wilensky, MD MBA FACS

    Diplomate, The American Board of Plastic Surgery; Fellow, The American College of Surgeons; CEO & Co-Founder, Braykion Inc

GACCF Reports

The GACCF was incorporated on September 14, 2016 and has the status of a private operating foundation with 501(c)(3) tax-exempt status.

Annual Report

Bylaws

Articles-of-Incorporation

Conflict-of-Interest

IRS-Exemption-Letter

Certificate-of-Amendment